BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16166046)

  • 1. Osteoporosis at presentation of childhood ALL: management with pamidronate.
    Goldbloom EB; Cummings EA; Yhap M
    Pediatr Hematol Oncol; 2005; 22(7):543-50. PubMed ID: 16166046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked osteoporosis and spontaneous vertebral fractures in children: don't forget, it could be leukemia.
    Bertuna G; Famà P; Lo Nigro L; Russo-Mancuso G; Di Cataldo A
    Med Pediatr Oncol; 2003 Nov; 41(5):450-1. PubMed ID: 14515385
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous pamidronate in juvenile osteoporosis.
    Shaw NJ; Boivin CM; Crabtree NJ
    Arch Dis Child; 2000 Aug; 83(2):143-5. PubMed ID: 10906023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate.
    Lucarelli S; Borrelli O; Paganelli M; Capocaccia P; Frediani T; Ferri F; Cucchiara S
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):533-5. PubMed ID: 17033531
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vertebral compression fractures--the first manifestations of acute lymphoblastic leukemia of childhood].
    Muszynska-Roslan K; Krawczuk-Rybak M; Krasowska I; Konstantynowicz J; Luczynski W
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1055-62. PubMed ID: 15951600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertebral compression fractures in acute lymphoblastic leukaemia and remodelling after treatment.
    Pandya NA; Meller ST; MacVicar D; Atra AA; Pinkerton CR
    Arch Dis Child; 2001 Dec; 85(6):492-3. PubMed ID: 11719337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome.
    Galli-Tsinopoulou A; Kyrgios I; Giza S; Giannopoulou EZ; Maggana I; Laliotis N
    Minerva Endocrinol; 2012 Sep; 37(3):283-9. PubMed ID: 22766895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate].
    Wüster C; Heilmann P
    Fortschr Med; 1997 Oct; 115(29):37-42. PubMed ID: 9445833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertebral compression fracture. An unusual presentation of childhood acute lymphoblastic leukaemia.
    Mehrotra S; Kumar A; Singh BN
    J Assoc Physicians India; 1990 Dec; 38(12):943-5. PubMed ID: 2096136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy.
    Sbrocchi AM; Rauch F; Jacob P; McCormick A; McMillan HJ; Matzinger MA; Ward LM
    Osteoporos Int; 2012 Nov; 23(11):2703-11. PubMed ID: 22297733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis.
    Heijckmann AC; Juttmann JR; Wolffenbuttel BH
    Neth J Med; 2002 Sep; 60(8):315-9. PubMed ID: 12481878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on fracture risk in life style-related diseases].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2014 Mar; 24(3):349-55. PubMed ID: 24576931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].
    Semler O; Land C; Schönau E
    Orthopade; 2007 Feb; 36(2):146-51. PubMed ID: 17252257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood leukemia presenting with back pain and vertebral compression fractures.
    Santangelo JR; Thomson JD
    Am J Orthop (Belle Mead NJ); 1999 Apr; 28(4):257-60. PubMed ID: 10220099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders.
    Wagner S; Poirot I; Vuillerot C; Berard C
    Ann Phys Rehabil Med; 2011 Sep; 54(6):348-58. PubMed ID: 21840280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment goals of osteoporosis].
    Hosoi T
    Clin Calcium; 2014 Mar; 24(3):385-9. PubMed ID: 24576935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy.
    Kim SH; Lim SK; Hahn JS
    Am J Med; 2004 Apr; 116(8):524-8. PubMed ID: 15063813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-osteoporosis drugs based on the guidelines for the Prevention and Treatment of Osteoporosis (2011 edition) ].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2014 Mar; 24(3):401-6. PubMed ID: 24576937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of i. v. bisphosphonate in pregnancy-associated osteoporosis--case study.
    Hellmeyer L; Kühnert M; Ziller V; Schmidt S; Hadji P
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):139-42. PubMed ID: 17318776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.